Cardiovascular models are moving to the bedside
Computational modeling can help fill gaps in how we develop and review new drugs and devices
Simulating molecular movement gives a more accurate view of binding sites.
Decades of steady progress in pharmacogenetics have unearthed hundreds of associations between genes and drug response. But the field has to solve some theoretical and practical issues before it can deliver on the promise of personalized drug therapy.
As algorithms evolve, computing power explodes, and scientists solve a greater number of 3-D protein structures, computer-aided design has the potential to dramatically cut the cost and time of drug discovery
"Fold-It" players find best protein conformations to fight cancer
OpenSim 2.0 promises greater opportunities for customization
How errors in data, software, and methodology can teach us how to do better